Answer
Prucalopride is excreted in human breast milk; although no effects on breast-fed infants are anticipated at therapeutic Resolor doses, limited human breastfeeding data mean deciding whether to discontinue breastfeeding or Resolor requires weighing benefits for the child and woman.
Sources for this answer
- Resolor 1mg film-coated tabletsTakeda UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 19Document updated
Sources checked